June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

November 6, 2014November 6, 2014

Study Finds Combination Treatment Effective For Advanced Melanoma

News

A recent clinical study titled “Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma: A Randomized Clinical Trial” and published in The Journal of the American Medical Association ... Read more

November 5, 2014November 5, 2014

Study Finds Lower Doses of Radiation Therapy Efficient To Treat Uveal Melanomas

News

In a recent study titled “Uveal Melanoma Treated With Iodine-125 Episcleral Plaque: An Analysis of Dose on Disease Control and Visual Outcomes”, published in the International Journal of Radiation Oncology.Biology.Physics, ... Read more

November 4, 2014November 4, 2014

Study Finds Relatives Of Melanoma Patients Positive For CDKN2A Mutations Have Higher Incidence Of Additional Cancers

News

In a recent study titled “Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic ... Read more

November 3, 2014

Lymphoseek Receives FDA Expanded Approval For Use In Melanoma and Breast Cancer Lymphatic Mapping

News

Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc 99m tilmanocept) injection has received a Food and Drug Administration (FDA) expanded approval for the inclusion of lymphatic mapping in solid tumors and sentinel lymph ... Read more

October 31, 2014October 31, 2014

PV-10 Shows Promise In Phase 2 Trial of Advanced Melanoma Patients

News

Recent results from Provectus Biopharmaceuticals investigational drug PV-10 have been published in the Annals of Surgical Oncology. A team of research led by Eric A. Wachter, PhD, CTO of Provectus Biopharmaceuticals, ... Read more

October 30, 2014

Study Finds Biochemotherapy Effective In High-Risk Melanoma Patients

News

A recent report published in the Journal of Clinical Oncology has found that 9 weeks of multiagent biochemotherapy can significantly improve relapse-free survival in patients with high-risk melanoma, when compared ... Read more

October 29, 2014

Metastasectomies Following Systemic Treatment Discussed in Panel

Melanoma, News

Surgery following systemic therapy against melanoma is a widely discussed topic in the world of clinical oncology. OncLive, a platform of information concerning cancers that include lung, leukemia, and melanoma, ... Read more

October 28, 2014October 28, 2014

UV radiation Can Transform Certain Peptides Into Damaging Reactive States

News

Exposure to near-UV radiation can lead to several diseases such as cataracts and skin cancer, and since peptides and proteins comprise 68% of the dry matter of cells they are ... Read more

October 27, 2014October 27, 2014

Researchers Develop Novel Nanoparticle To Deliver Melanoma Drug

News

Researchers from Penn State College of Medicine have published results in the journal Molecular Cancer Therapeutics, titled “Nanolipolee-007, a Novel Nanoparticle-Based Drug Containing Leelamine for the Treatment of Melanoma”, showing ... Read more

October 24, 2014October 24, 2014

Phase I SBIR Grant Awarded to Radiomedix and Viewpoint MT For Metastatic Melanoma Theranostics

News

RadioMedix, Inc. and Viewpoint Molecular Targeting LLC have been awarded a grant by the Small Business Innovation Research (SBIR) program from the National Cancer Institute. This Phase I award of ... Read more

October 23, 2014October 23, 2014

Study Finds New Subpopulation of Melanoma Cells

News

In a recent study titled “Vascular channels formed by subpopulations of PECAM1+ melanoma cells”, published in Nature Communications, a team of researchers from the University of North Carolina School of Medicine, ... Read more

October 22, 2014October 22, 2014

Study Links Melanoma Thickness To Patient Death Rates

News

Researchers from the QIMR Berghofer Medical Research Institute, Brisbane, Australia, have published a study in the Journal of Investigative Dermatology, titled “More people die from thin melanomas (<1mm) than thick melanomas ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group